chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am 72 year old female obesity, arthritis, diabetes, cancer survivor. I received Pfizer second dose and had the following side effects. Day of vaccine and day after, slept through for 48 hours. Day four I felt off, a bit dizzy. Day five my lower joints were weak, had trouble walking. Also at this time I experienced severe brain fog, everything  was "graved out." It felt like I was drugged. I fell down and couldn't get up. EMT called to get me up. Still felt gray and wobbly so went back to bed. It took 10 days for all symptoms to resolve. The persistent sensation of being drugged was unique.
Tingling and hot burning feeling all through my body and mouth and throat it's worst at night cant sleep feel like my insides on fire.
I was a 48 year old woman(at the time of my vaccine) who had not had a mensural cycle in 12 months, rendering me menopausal. Nine days after my first injection, I experienced break through bleeding for roughly 24 hours, requiring a tampon to manage the bleeding.  By Monday, April 5 the bleeding had stopped. I have not had any bleeding since that day.
Information has been received form a 27 year old male who on 9/15/99 was vaccinated with Hep B vaccine. On 9/17/99 the pt experienced blurred vision. In addition, he stated that numbers on a clock looked fuzzy. No further is available.
No adverse event; Vaccines were thawed on 13JAN2023 and 4 doses were administered on 17FEB2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines were thawed on 13JAN2023 and 4 doses were administered on 17FEB2023) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 17-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines were thawed on 13JAN2023 and 4 doses were administered on 17FEB2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines were thawed on 13JAN2023 and 4 doses were administered on 17FEB2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccines were thawed on 13JAN2023 and 4 doses were administered on 17FEB2023).    No concomitant medications was reported.  Vaccines were thawed on 13-JAN-2023 and 4 doses were administered on 17-FEB-2023. No symptoms have been reported.  No treatment medications was reported.  This case contains information about patient-2 out of 4.   This case was linked to US-MODERNATX, INC.-MOD-2023-712275, US-MODERNATX, INC.-MOD-2023-712328, US-MODERNATX, INC.-MOD-2023-712038 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-712275: US-MODERNATX, INC.-MOD-2023-712328: US-MODERNATX, INC.-MOD-2023-712038:Master case
Had shot at noon on 10/16/13. About 5:30 she got really cold and started shaking. BP 150/125 - it's usually very low (120/70). Went to ER at 8:30 PM. Temperature was 102.5. Started fluids and did tests - bloodwork, urine, chest xray. Arm never red or sore. Came home after 4 hrs. Ran slight fever for another 24 hrs. Very tired for 4 days.
I experienced weakness, fatigue, lightheadedness for the most of day after receiving the shot. Symptoms reduced with rest, plenty of water. Symptoms resolved by morning of 1.26.2021
hands turned red and swollen, then quickly progressed to red face/cheeks, hives on chest and arms within 10 minutes, evaluated by EMS, 50mg Benadryl given po, epi given IM by EMS also, transported by ambulance to ED
This spontaneous report as received from a male consumer of unknown age refers to himself. On unspecified date, the patient was vaccinated with PNEUMOVAX23 (dose, indicating, route and lot not reported). No concomitant medications were reported. The consumer reported that on unspecified date, he was vaccinated with PNEUMOVAX23 and he believed that he and his wife received the PNEUMOVAX23 twice. He does not have any adverse experiences. At the time of the report the patient's outcome was unknown. Additional information is not expected. This is one of several reports received from the same source.
I received the Pfizer booster Jan 29, 2022 at 5:40pm.  I had initially received the J&J April 5, 2021.  I was fine until 9:30pm.  I was watching a movie and started hearing/feeling my heart beating.  It started in my neck.  I checked my oximeter and my pulse was 133 and the oximeter started beeping at me.  This initialized a fear factor and then at the highest it was at 141 (pulse).  My husband decided we needed to go have me be seen at the ER as I am unclear on where after hours clinics are in my area and didn?t have time to look into.  At the ER my pulse went down but still stayed in a higher range for a while.  I was not clear and still not clear if an actual ?reaction? from the shot or if my nerves played a factor.  I have never experienced my pulse getting to that rate for no reason.  The doctor said he had not seen people have this type of reaction and wasn?t clear if it was because of the booster or a combination of that and a panic attack.  I feel it had to have something to do with it as I have not experienced this with any panic attack in the past and haven?t had a panic attack for 15 years.   They told me to keep track of my pulse and if it gets more than 120 to come back in.   It has (so far today) stayed consistent in 80?s and 90?s.
Patient described feeling "dizzy." Felt faint and slumped to floor. Became immediately responsive, vital signs stable throughout. Patient covered with blanket. Patient left clinic with friends.
A 49 year old male patient was being treated with Oncotice for carcinoma in situ of the bladder since 22 August 2005.  After the second instillation on 29 August 2005 the patient experienced low-grade fever, night sweats with chills and hematuria on the same day as the instillation.  The complaints resolved the next day. The patient did not measure his temperature, therefore it is uncertain if he actually had an elevated body temperature. He experienced the same events after the third instillation on 6 September 2005.  The events resolved the next day.  He treated the fever with a non-steroidal anti-inflammatory (unspecified) drug and that improved his fever.  Corrective treatment: Non-steroidal anti-inflammatory (unspecified) drug
Information has been received from the physician in a literature report. This case report refers to a 20-year-old female patient. The patient's concurrent condition included myopia (spherical equivalent: -4) and there was no history of headache, systemic or ocular disease, or ocular trauma; no neurological, auditory, or skin changes were evident. A recent pregnancy test result had been negative. On an unknown date, the patient was vaccinated with second dose of GARDASIL (dose, frequency and route were unspecified) and was vaccinated with first dose 7 months previously. On an unknown date, the patient presented with acute-onset blurred vision bilaterally 3 weeks after her second injection of GARDASIL. Best-corrected visual acuity (BCVA) was 20/60 in both eyes. Aqueous flare was noted with occasional inflammatory cells in the anterior chamber and vitreous. There were no keratic precipitates. The patient had bilateral diffuse neurosensory retinal detachments at the posterior poles with yellowish subretinal exudation at the fovea, Fluorescein angiography revealed bilateral disc leakage, with staining of a peripheral retinal vessel in the left eye. Late pooling of fluorescein within the exudative retinal detachments was noted, and it was unclear whether any diffuse leakage at the level of the RPE contributed to sequestration of subretinal fluid, midperipheral yellowish choroidal lesions, seen on color photography, correlated spatially with foci of hypofluorescence during the mid-phase of the angiogram, Spectral-domain optical coherence tomography (SD-OCT) with enhanced-depth imaging confirmed the presence of multiple elevations of the neurosensory retina with intervening areas of persistent retinal attachment; the subretinal fluid exhibited a degree of hyper-reflectivity, the choroid was thickened at the posterior pole, especially below the fovea, beyond the depth range of the OCT device, subfoveal choroidal thickness measured by ultrasound exceeded 1,000 um, laboratory findings revealed a raised erythrocyte sedimentation rate (29 mm/h) and positive HLA-DRB1 *0405 haplotype (Table), chest X-ray findings were normal. The patient was started on oral prednisolone 60 mg daily for 2 weeks, followed by a tapering regimen leading to discontinuation at 6 weeks due to rapid improvement. One month after presentation, the anterior uveitis and exudative retinal detachments had resolved and visual acuity improved to 20/25 bilaterally, during follow-up, choroidal thickness reduced to 400 um at 1 month and 300 um at 3 months, at 5 months, choroidal thickness had stabilized at 300 um, with BCVA of 20/20 and 20/25 in the right and left eyes, respectively. The outcome of bilateral acute visual loss was recovering (reported as improved). The reporter considered the events to be related to GARDASIL. The events were considered to be medically significant (serious). Additional information has been requested.
Patient started having generalized weakness, fast heart rate along with irregular heartbeat approximately 4 to 5 days back.  He was seen in the outpatient clinic and was diagnosed with atrial fibrillation on 9/23/2021.  EKG showed atrial fibrillation, patient was started on metoprolol 12.5 mg p.o. twice daily.  Outpatient echocardiogram and TSH was ordered.  TSH came within normal limits.  As patient's CHA2DS2-VASc score is 0 he was not started on any anticoagulation.  Patient had a phone consult with physician on 9/24/2021, as his heart rate was still between 130s to 140s, his metoprolol was increased to 25 mg twice daily.  For the last 3 days patient had been having some epigastric area/lower chest pain.  There is some reproducible component to it.  According to him since yesterday he had been having shortness of breath and was unable to lie down and had to sleep hunched over dinner table.  He also felt that with increase in activity he was having more shortness of breath and epigastric pain.
malaise few hr p/vax; 14 hr later woke up w/h/a, shoulder, neck & upper arm pain, photophobia w/mild nausea; no vomiting or diarrhea; tx for h/a w/Fioricet & rest;
This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported. On 02-FEB-2018, the patient was vaccinated with an improperly stored dose of M-M-R II lot # N013279, expiration date 28-APR-2019, for prophylaxis (Strength, dose, route and frequency were not reported). The M-M-R II was reconstituted with a properly stored sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported). The temperature excursion was of 9°C to 25°C, during 8 minutes. A previous temperature excursion was not reported. A digital data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1802USA007574: US-009507513-1802USA007580: US-009507513-1802USA007576: US-009507513-1802USA007577: US-009507513-1802USA007578: US-009507513-1802USA007579: US-009507513-1802USA007573: US-009507513-1802USA006448: US-009507513-1802USA007575:
About six hours after receiving my shot, my arm became extremely sore, as to be expected.  Circa 9pm I began to have  significant trouble breathing, experienced acute pain in my abdomen, and began to hear ringing in my ears combined with feeling like I was going to pass out. I didn?t feel dizzy, rather I started getting tunnel vision that blocked out more of my field of view as the ringing increased.  Circa 11pm, I lost consciousness while trying to move and collapsed on the floor. My wife called 911 while I was unresponsive, and I regained consciousness while being attended to by EMTs who checked my vitals. Around 12am I didn?t feel like I was going to lose consciousness again, and the EMTs recommended I be taken to the hospital. Since I was feeling better I politely declined.   Today I am still feeling foggy and have joint pain (in addition to some bruising from falling after losing consciousness , but I no longer have the acute abdominal pain.
On 1/21, pt came reported on AE at local injection site. According to pt, it developed on 01/15 with symptoms of swelling, redness, tender to touch, and itching. The size was about a quarter. Pt took Benadryl & Cortisone cream and had shown great improvement / minimal sign/ symptom at time of reporting. No other complaints reported.
Initial report received on 15/Feb/2oo6 from a health care professional. A 17 month old had received an administration (route and site not reported) of FLUZONE SV, (lot number not reported) on an unspecified day in 2006. The next day, the patient developed a low grade fever and mild vomiting. No other information was provided. At the time of this report the patient had recovered from these events. Follow up information received on 17/Mar/2006 from a health care provider. The date of vaccination was 12/Jan/2006, and the adverse event onset date was 13/Jan/2006. The lot number for Fluzone is provided as U1765FA, and the vaccination was administered intramuscularly. Per the reporter, the patient had a second dose of "flu vaccine" on 15/Feb/2006 without any problems, and "the physician felt the symptoms were due to a virus (not the vaccine)." Adverse events have been amended to reflect this new information.
Rt side facial sharp shooting nerve pain. Started on 12/17/2021. and ended 1/7/2022
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
inconsolable, high pitched crying, rapid eye movement for several seconds w/shaking arms/legs-unable to stop shaking w/holding;arms/legs shook for 4-5sec, eye movement x 1sec;high pitched cry lasted 1 1/2hr;diaphoretic;
cough; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73 year-old female patient received COVID-19 Vaccine - Manufacturer Unknown, administration date Nov2020 (Batch/Lot number: unknown) as dose 1, single and administration date Dec2020 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Atrial fibrillation", start date: 2000 (ongoing); "Heart murmur", start date: 2000 (ongoing); "chickenpox" (unspecified if ongoing), notes: chickenpox 16 times until she was 16 years old and then she never had the chicken pox after that.; "Operations" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Flu vaccine (she was sick for 5 days; diarrhea; vomiting; fever; felt like crap). The following information was reported: COUGH (non-serious), outcome "unknown", described as "cough".  Additional information: Patient reported she already had 2 doses of a Covid-19 Vaccine but is not sure which one, she does not know because she lives in a new assisted living facility, and they gave her those Covid-19 Vaccine doses. Caller clarified that she called to ask if she can get Pfizer Covid-19 Vaccine relative to her clinical history, prior to considering being administered the Pfizer Covid-19 Vaccine. She mentioned on the paper she got it says everything about heart and all kinds of stuff, and that is scary you know, she does not know if she is allowed to get the Pfizer Covid-19 Vaccine or not. She hopes she does not die, she does not want to die. The inbound transfer agent advised caller to ask somebody there; but caller has only been there since 01Sep2021.   Follow-up (27Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a certified medical assistant, refers to multiple unspecified patients of unknown age and gender. No medical history and concurrent conditions were reported for the patients. On an unspecified date in 2015, starting from and after 03-AUG-2015, the unspecified patients were vaccinated with improperly stored doses of PNEUMOVAX 23 lot # L003188, expiration date 06-JUL-2016 (dose, frequency and route were not reported). No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports from the same source. Additional information has been requested.
1st dose in Dec2021, okay to give 2nd dose now?; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (Received 1st dose on December 2021).   On an unknown date, the patient did not receivedthe 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose in Dec2021, okay to give 2nd dose now?). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 13 Mar 2023 It was reported that the patient received one dose of Shingrix in December 2021 and if it was okay to give the second dose nowor if the vaccination series have to be restarted. The patient did not received 2nd dose till the time of reporting which led to incomplete course of vaccination.
Information has been received from a registered nurse concerning a 43 year old female, with no pertinent medical history and no drug reactions or allergies, who on 8/21/06 was vaccinated IM with a 1ml dose of hepatitis A virus vaccine inactivated (lot 653142/1014R). Concomitant therapy included rosuvastatin calcium (Crestor). On 9/1/06 the pt presented with meningitis after receiving hepatitis A virus vaccine inactivated. She had a stiff neck, vision disturbances, headaches and fever. She went to the hospital on 9/2/06 and was released, but she went back to the hospital on 9/5/06 and was admitted. She is till hospitalized. Diagnostic test of a spinal tap and blood work were performed. Meningitis was considered to be disabling. it was reported that the pt is presently recovering. No product quality complaint. Additional information has been requested.
1037am Reports Difficulty Swallowing 1043 Benadryl 25mg and Oxygen mask  1058am Patient reported resolution of symptoms. Patient escorted and ER precautions given.
I had the vaccine on 01/16/2021 and then at the end of the month my husband got Covid and we both had the vaccine already. Of course he gave it to me, so the 02/01/2021 he tested positive and then he had the antibody infusions and a couple of days later I tested positive and I had the infusions on 02/05/2021. About 2 weeks later I got very sick, back ache and chest pains so I went to the ER so I ended up with blood cots in my lungs. They did scans and tons of blood tests, heart scan, lung scans. I have been on blood thinners since them. After Covid and everything I had me second dose this past Friday. So far I am doing okay, I am feeling a little bit dizzy.
SYMPTOMS LIKE FLU COLD /CHILLS; DIARRHEA; SORE THROAT; SLIGHT HEADACHES; ITCH; This spontaneous report received from a patient concerned an 85 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, diabetes, sciatic nerve pain, arthritis pain, and allergy (dust, cigarettes, environmental trees, grass).The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On 26-MAR-2021, the subject experienced itch. On 26-MAR-2021, the subject experienced slight headaches. On 30-MAR-2021, the subject experienced symptoms like flu cold /chills. On 30-MAR-2021, the subject experienced diarrhea. On 30-MAR-2021, the subject experienced sore throat. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slight headaches on 31-MAR-2021, was recovering from itch, diarrhea, and sore throat, and had not recovered from symptoms like flu cold /chills. This report was non-serious.
Redness and itching at the site of injection in the left arm where PREVNAR was given for more than 5 days.
L axillary lymphadenopathy that developed after 2nd vaccine. reduced to size of golf ball after 1 year then increased in size after booster vaccine
reaction to her 2nd Covid vaccine, pt started having mild fever, body aches, sore throat, coughed up blood, bloody nose, headaches and light sensitivity,  consistent coughing and phlegm, brown to green mucus  Elevated to bronchitis
Post-menopausal vaginal bleeding. Light bleeding for one day. Had never occurred since 2008 menopause.
Information has been received from a registered nurse referring to 3 patients of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 12-AUG-2015, the patients were vaccinated with ZOSTAVAX (0.65 ml, Lot#L011529, expiration date: 03-JUL-2016), which were improperly stored for 9 days (Incorrect product storage). The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.